跳至主要内容
临床试验/NL-OMON56591
NL-OMON56591尚未招募不适用

Determining the safety and feasibility of optical coherence tomography and near infrared fluorescence: a prospective pilot intervention study - Safety and feasibility of immuno-OCT (DETOUR)

niversitair Medisch Centrum Groningen0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • Indication for a therapeutic endoscopy procedure (EMR or ESD);
  • Age >= 18;
  • Written informed consent.

排除标准

  • Patients younger than 18 years old;
  • Submucosal and invasive EAC or CRC;
  • Radiation therapy for esophageal or colorectal cancer;
  • History of infusion reactions to Bevacizumab or other monoclonal antibodies;
  • Chemotherapy, immunotherapy or surgery 28 days before administration of the
  • Non-adjustable hypertension;
  • Medical or psychiatric conditions that compromise the patient*s ability to
  • give informed consent;
  • Pregnancy or breast feeding; a negative pregnancy test must be available for
  • women of childbearing potential.

研究者

相似试验